CDIO is trading 5.8% up today at $2.20 as the stock builds on recent momentum, notably driven by: - The company's announcement on June 24-25, 2026, that Atlas Healthcare Physicians will provide coverage for its AI-powered Epi+Gen CHDâ„¢ and PrecisionCHDâ„¢ tests. - Continued enthusiasm around its AI-based epigenetic cardiovascular diagnostics platform. - A broader market trend of traders leaning into the AI health diagnostics theme.